HVIA
PFE icon

Hudson Valley Investment Advisors’s Pfizer PFE Stock Holding History

Hudson Valley Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
10,405
-1,504
-13% -$39.3K 0.03% 135
2026
Q1 		$334K Sell
11,909
-4,535
-28% -$121K 0.04% 126
2025
Q4 		$409K Sell
16,444
-12,320
-43% -$311K 0.05% 119
2025
Q3 		$733K Sell
28,764
-646
-2% -$15.9K 0.08% 113
2025
Q2 		$713K Sell
29,410
-6,982
-19% -$163K 0.08% 112
2025
Q1 		$922K Sell
36,392
-119,705
-77% -$3.13M 0.11% 98
2024
Q4 		$4.14M Sell
156,097
-21,117
-12% -$573K 0.47% 58
2024
Q3 		$5.13M Buy
177,214
+43,358
+32% +$1.26M 0.57% 54
2024
Q2 		$3.96M Buy
133,856
+2,831
+2% +$77.9K 0.51% 61
2024
Q1 		$3.64M Buy
131,025
+5,919
+5% +$164K 0.44% 64
2023
Q4 		$3.7M Sell
125,106
-6,941
-5% -$210K 0.51% 63
2023
Q3 		$4.38M Sell
132,047
-1,130
-0.8% -$40K 0.62% 53
2023
Q2 		$4.88M Sell
133,177
-11,853
-8% -$461K 0.66% 47
2023
Q1 		$5.92M Sell
145,030
-839
-0.6% -$36.2K 0.83% 35
2022
Q4 		$7.47M Sell
145,869
-3,739
-2% -$179K 1.13% 25
2022
Q3 		$6.55M Buy
149,608
+20,266
+16% +$985K 1.05% 27
2022
Q2 		$6.78M Sell
129,342
-10,738
-8% -$547K 1.06% 25
2022
Q1 		$7.25M Sell
140,080
-3,401
-2% -$176K 0.97% 29
2021
Q4 		$8.47M Buy
143,481
+3,505
+3% +$174K 1.32% 22
2021
Q3 		$6.02M Buy
139,976
+12,000
+9% +$532K 1.03% 29
2021
Q2 		$5.01M Sell
127,976
-10,883
-8% -$423K 0.87% 36
2021
Q1 		$5.03M Sell
138,859
-3,582
-3% -$127K 0.9% 36
2020
Q4 		$5.24M Sell
142,441
-9,368
-6% -$344K 1% 37
2020
Q3 		$5.29M Buy
151,809
+33
+0% +$1.16K 1.14% 29
2020
Q2 		$4.71M Buy
151,776
+2,728
+2% +$92.7K 1.09% 32
2020
Q1 		$4.62M Sell
149,048
-354
-0.2% -$12.1K 1.28% 22
2019
Q4 		$5.55M Sell
149,402
-13,402
-8% -$477K 1.19% 25
2019
Q3 		$5.55M Sell
162,804
-3,599
-2% -$131K 1.29% 21
2019
Q2 		$6.84M Sell
166,403
-3,394
-2% -$135K 1.58% 15
2019
Q1 		$6.84M Sell
169,797
-36,213
-18% -$1.45M 1.66% 14
2018
Q4 		$8.53M Buy
206,010
+28,327
+16% +$1.18M 1.97% 10
2018
Q3 		$7.43M Sell
177,683
-520
-0.3% -$20K 1.72% 15
2018
Q2 		$6.13M Buy
178,203
+1,243
+0.7% +$42.5K 1.51% 19
2018
Q1 		$5.96M Buy
176,960
+284
+0.2% +$9.76K 1.5% 17
2017
Q4 		$6.07M Sell
176,676
-566
-0.3% -$19.3K 1.5% 15
2017
Q3 		$6M Sell
177,242
-2,980
-2% -$95.8K 1.56% 14
2017
Q2 		$5.74M Sell
180,222
-6,146
-3% -$194K 1.58% 12
2017
Q1 		$6.05M Buy
186,368
+4,014
+2% +$127K 1.69% 14
2016
Q4 		$5.62M Buy
182,354
+11,266
+7% +$344K 1.66% 15
2016
Q3 		$5.5M Buy
171,088
+4,300
+3% +$144K 1.71% 15
2016
Q2 		$5.57M Buy
166,788
+1,255
+0.8% +$40.1K 1.79% 14
2016
Q1 		$4.66M Buy
165,533
+4
+0% +$114 1.51% 19
2015
Q4 		$5.07M Buy
165,529
+5
+0% +$157 1.58% 15
2015
Q3 		$4.93M Sell
165,524
-2,474
-1% -$79.3K 1.6% 17
2015
Q2 		$5.34M Sell
167,998
-1,666
-1% -$54.3K 1.67% 17
2015
Q1 		$5.6M Buy
169,664
+2,374
+1% +$75.5K 1.89% 14
2014
Q4 		$4.94M Buy
167,290
+2,186
+1% +$62.7K 2.02% 15
2014
Q3 		$4.63M Buy
165,104
+5,432
+3% +$152K 1.97% 17
2014
Q2 		$4.5M Sell
159,672
-3,940
-2% -$112K 1.96% 17
2014
Q1 		$4.99M Buy
163,612
+3,285
+2% +$97.9K 2.13% 13
2013
Q4 		$4.66M Buy
160,327
+2,855
+2% +$83.1K 2.05% 15
2013
Q3 		$4.29M Sell
157,472
-4,956
-3% -$135K 2.09% 16
2013
Q2 		$4.32M Buy
+162,428
New +$4.49M 2.07% 13

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hudson Valley Investment Advisors's PFE Position: Q2 2026 in Review

Hudson Valley Investment Advisors reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $39.3K and leaving 10,405 shares worth $251K. The position accounts for 0.03% of the portfolio, ranked #135.

Hudson Valley Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.53M in Q4 2018. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hudson Valley Investment Advisors held 10,405 shares of Pfizer worth $251K as of Q2 2026.
  • Hudson Valley Investment Advisors sold 1,504 Pfizer shares in Q2 2026, an estimated $39.3K.
  • Pfizer made up 0.03% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #135 holding.
  • Hudson Valley Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Hudson Valley Investment Advisors's Pfizer position peaked at $8.53M in Q4 2018.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.